Literature DB >> 33535791

Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus.

Kirsty E Waddington1,2, George A Robinson2,3, Leda Coelewij1,2, Elvira Chocano1, Thomas McDonnell2, Filipa Farinha2, Junjie Peng2,3, Pierre Dönnes2,4, Edward Smith2, Sara Croca2, Jyoti Bakshi2, Maura Griffin5, Andrew Nicolaides5,6, Anisur Rahman2, Elizabeth C Jury2, Ines Pineda-Torra1.   

Abstract

[Figure: see text].

Entities:  

Keywords:  atherosclerosis; lipoprotein; lupus erythematosus, systemic; machine learning; metabolomics

Mesh：

Substances：

Year:  2021        PMID： 33535791      PMCID： PMC7610443          DOI： 10.1161/ATVBAHA.120.315321

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   10.514


  75 in total

1.  Carotid artery plaque echomorphology and its association with histopathologic characteristics.

Authors:  Konstantinos Spanos; Ioannis Tzorbatzoglou; Paraskevi Lazari; Dimitrios Maras; Athanasios D Giannoukas
Journal:  J Vasc Surg       Date:  2018-05-24       Impact factor: 4.268

Review 2.  Effect of inflammation on HDL structure and function.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  Curr Opin Lipidol       Date:  2016-10       Impact factor: 4.776

3.  Role of Low-Density Lipoprotein in Early Vascular Aging Associated With Systemic Lupus Erythematosus.

Authors:  Hua-Chen Chan; Hsiu-Chuan Chan; Chan-Jung Liang; Hsiang-Chun Lee; Hung Su; An-Sheng Lee; Jentaie Shiea; Wen-Chan Tsai; Tsan-Teng Ou; Cheng-Chin Wu; Chih-Sheng Chu; Richard A Dixon; Liang-Yin Ke; Jeng-Hsien Yen; Chu-Huang Chen
Journal:  Arthritis Rheumatol       Date:  2020-04-30       Impact factor: 10.995

4.  ¹H NMR-based metabolomic study of metabolic profiling for systemic lupus erythematosus.

Authors:  X Ouyang; Y Dai; J L Wen; L X Wang
Journal:  Lupus       Date:  2011-10-05       Impact factor: 2.911

5.  Mortality in systemic lupus erythematosus.

Authors:  S Bernatsky; J-F Boivin; L Joseph; S Manzi; E Ginzler; D D Gladman; M Urowitz; P R Fortin; M Petri; S Barr; C Gordon; S-C Bae; D Isenberg; A Zoma; C Aranow; M-A Dooley; O Nived; G Sturfelt; K Steinsson; G Alarcón; J-L Senécal; M Zummer; J Hanly; S Ensworth; J Pope; S Edworthy; A Rahman; J Sibley; H El-Gabalawy; T McCarthy; Y St Pierre; A Clarke; R Ramsey-Goldman
Journal:  Arthritis Rheum       Date:  2006-08

6.  Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.

Authors:  Elisabet Svenungsson; Daniel Engelbertsen; Maria Wigren; Johanna T Gustafsson; Iva Gunnarsson; Kerstin Elvin; Kerstin Jensen-Urstad; Gunilla Nordin Fredrikson; Jan Nilsson
Journal:  Clin Exp Immunol       Date:  2015-06-22       Impact factor: 4.330

Review 7.  Cardiovascular Risk in Perimenopausal Women.

Authors:  John C Stevenson; Sophia Tsiligiannis; Nick Panay
Journal:  Curr Vasc Pharmacol       Date:  2019       Impact factor: 2.719

8.  Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.

Authors:  Anette Varbo; Marianne Benn; Anne Tybjærg-Hansen; Børge G Nordestgaard
Journal:  Circulation       Date:  2013-08-07       Impact factor: 29.690

9.  Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study.

Authors:  Matthew J McQueen; Steven Hawken; Xingyu Wang; Stephanie Ounpuu; Allan Sniderman; Jeffrey Probstfield; Krisela Steyn; John E Sanderson; Mohammad Hasani; Emilia Volkova; Khawar Kazmi; Salim Yusuf
Journal:  Lancet       Date:  2008-07-19       Impact factor: 79.321

10.  Metabolic disturbances associated with systemic lupus erythematosus.

Authors:  Tianfu Wu; Chun Xie; Jie Han; Yujin Ye; Jim Weiel; Quan Li; Irene Blanco; Chul Ahn; Nancy Olsen; Chaim Putterman; Ramesh Saxena; Chandra Mohan
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240
View more
  6 in total

Review 1.  Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges.

Authors:  Junjie Peng; Elizabeth C Jury; Pierre Dönnes; Coziana Ciurtin
Journal:  Front Pharmacol       Date:  2021-09-30       Impact factor: 5.810

Review 2.  Sex Differences in Lipid Metabolism: Implications for Systemic Lupus Erythematosus and Cardiovascular Disease Risk.

Authors:  George A Robinson; Ines Pineda-Torra; Coziana Ciurtin; Elizabeth C Jury
Journal:  Front Med (Lausanne)       Date:  2022-05-31

Review 3.  Lipid metabolism in autoimmune rheumatic disease: implications for modern and conventional therapies.

Authors:  George Robinson; Ines Pineda-Torra; Coziana Ciurtin; Elizabeth C Jury
Journal:  J Clin Invest       Date:  2022-01-18       Impact factor: 14.808

Review 4.  Dysfunctional Vascular Endothelium as a Driver of Atherosclerosis: Emerging Insights Into Pathogenesis and Treatment.

Authors:  Steven R Botts; Jason E Fish; Kathryn L Howe
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

Review 5.  Precision Medicine Approaches with Metabolomics and Artificial Intelligence.

Authors:  Elettra Barberis; Shahzaib Khoso; Antonio Sica; Marco Falasca; Alessandra Gennari; Francesco Dondero; Antreas Afantitis; Marcello Manfredi
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

6.  Metabolomics Defines Complex Patterns of Dyslipidaemia in Juvenile-SLE Patients Associated with Inflammation and Potential Cardiovascular Disease Risk.

Authors:  George A Robinson; Junjie Peng; Ines Pineda-Torra; Coziana Ciurtin; Elizabeth C Jury
Journal:  Metabolites       Date:  2021-12-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.